216 related articles for article (PubMed ID: 6334720)
21. Immunotherapy of established tumors in mice by intratumoral injection of an adenovirus vector harboring the human IL-2 cDNA: induction of CD8(+) T-cell immunity and NK activity.
Slos P; De Meyer M; Leroy P; Rousseau C; Acres B
Cancer Gene Ther; 2001 May; 8(5):321-32. PubMed ID: 11477452
[TBL] [Abstract][Full Text] [Related]
22. Bimodal effects of MVE-2 on cytotoxic activity of natural killer cell and macrophage tumoricidal activities.
Piccoli M; Saito T; Chirigos MA
Int J Immunopharmacol; 1984; 6(6):569-76. PubMed ID: 6511143
[TBL] [Abstract][Full Text] [Related]
23. Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages.
Harmel RP; zbar B
J Natl Cancer Inst; 1975 Apr; 54(4):989-92. PubMed ID: 1127729
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CD1-restricted natural killer T cells.
Andrews KJ; Ribas A; Butterfield LH; Vollmer CM; Eilber FC; Dissette VB; Nelson SD; Shintaku P; Mekhoubad S; Nakayama T; Taniguchi M; Glaspy JA; McBride WH; Economou JS
Cancer Res; 2000 Nov; 60(22):6457-64. PubMed ID: 11103813
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulatory and therapeutic properties of bestatin in mice.
Talmadge JE; Lenz BF; Pennington R; Long C; Phillips H; Schneider M; Tribble H
Cancer Res; 1986 Sep; 46(9):4505-10. PubMed ID: 2942238
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
27. Studies on the mechanisms of action of the immunomodulator Bestatin in various screening test systems.
Schorlemmer HU; Bosslet K; Dickneite G; Lüben G; Sedlacek HH
Behring Inst Mitt; 1984 May; (74):157-73. PubMed ID: 6383322
[TBL] [Abstract][Full Text] [Related]
28. Effect of maleic anhydride-divinyl ether copolymers on experimental M109 metastases and macrophage tumoricidal function.
Pavlidis NA; Schultz RM; Chirigos MA; Luetzeler J
Cancer Treat Rep; 1978 Nov; 62(11):1817-22. PubMed ID: 728899
[TBL] [Abstract][Full Text] [Related]
29. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
30. Augmentation of natural cell activity in tumor-bearing and normal mice by MVE-2.
Budzynski W; Chirigos M; Gruys E
Cancer Immunol Immunother; 1987; 24(3):253-8. PubMed ID: 3594488
[TBL] [Abstract][Full Text] [Related]
31. Differential sensitivity of metastatic versus nonmetastatic mammary tumor cells to macrophage-mediated cytostasis.
Yamashina K; Fulton A; Heppner G
J Natl Cancer Inst; 1985 Oct; 75(4):765-70. PubMed ID: 3862907
[TBL] [Abstract][Full Text] [Related]
32. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
Merritt RE; Yamada RE; Crystal RG; Korst RJ
J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of experimental tumor metastasis by selective activation of natural killer cells.
Hanna N
Cancer Res; 1982 Apr; 42(4):1337-42. PubMed ID: 6277482
[TBL] [Abstract][Full Text] [Related]
34. Effect of pyran copolymer on activation of murine macrophages: evidence for incomplete activation by use of functional markers.
Adams DO; Johnson WJ; Marino PA; Dean JH
Cancer Res; 1983 Aug; 43(8):3633-7. PubMed ID: 6861134
[TBL] [Abstract][Full Text] [Related]
35. Effect of maleic anhydride-vinyl ether on the lymphocyte subpopulations of tumor-bearing, irradiated mice.
Stylos WA; Chirigos MA; Lengel CR; Weiss JF
Cancer Treat Rep; 1978 Nov; 62(11):1831-6. PubMed ID: 310344
[TBL] [Abstract][Full Text] [Related]
36. Augmentation of NK cell activity in tissue specific sites by liposomes incorporating MTP-PE.
Talmadge JE; Schneider M; Collins M; Phillips H; Herberman RB; Wiltrout RH
J Immunol; 1985 Aug; 135(2):1477-83. PubMed ID: 4008928
[TBL] [Abstract][Full Text] [Related]
37. Interleukin 18 induces the sequential activation of natural killer cells and cytotoxic T lymphocytes to protect syngeneic mice from transplantation with Meth A sarcoma.
Micallef MJ; Tanimoto T; Kohno K; Ikeda M; Kurimoto M
Cancer Res; 1997 Oct; 57(20):4557-63. PubMed ID: 9377569
[TBL] [Abstract][Full Text] [Related]
38. Immune response of BALB/c X DBA/2F1 mice to a tumor allograft during pyran copolymer-induced tumor enhancement.
Schultz RM; Woods WA; Mohr SJ; Chirigos MA
Cancer Res; 1976 May; 36(5):1641-6. PubMed ID: 1268825
[TBL] [Abstract][Full Text] [Related]
39. Ability of the immunomodulating dipeptide bestatin to activate cytotoxic mononuclear phagocytes.
Schorlemmer HU; Bosslet K; Sedlacek HH
Cancer Res; 1983 Sep; 43(9):4148-53. PubMed ID: 6871856
[TBL] [Abstract][Full Text] [Related]
40. Intrinsic resistance to herpes simplex virus type 1 infection in liver Kupffer cells and peritoneal macrophages from normal and immunomodulator-treated mice.
Hendrzak JA; Pinto AJ; Morahan PS
Nat Immun; 1992; 11(1):26-33. PubMed ID: 1611279
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
